Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice-Reference-Cited by-同舟云学术

Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice

Published:2018-11-06 Issue:5 Volume:30 Page:441-445
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Esposito Maria¹,Prignano Francesca²,Rongioletti Franco³,Hansel Katharina⁴,Bianchi Leonardo⁴,Pescitelli Leonardo²,Lazzeri Linda²,Ricceri Federica²,Mugheddu Cristina³,Bavetta Mauro¹,Zangrilli Arianna¹,Bianchi Luca¹,Bini Vittorio⁵,Stingeni Luca⁴

Affiliation:

1. Department of Dermatology, University of Rome ‘Tor Vergata’, Rome, Italy;

2. Department of Dermatology, University of Florence, Firenze, Italy;

3. Department of Medical Sciences and Public Health, Section of Dermatology, University of Cagliari, Cagliari, Italy;

4. Department of Medicine, Section of Clinical, Allergological and Venereological Dermatology, University of Perugia, Perugia, Italy;

5. Department of Medicine, Medicine, Endocrine and Metabolic Sciences Section, University of Perugia, Perugia, Italy

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2018.1529382